Recurrent pyoderma gangrenosum and cystic acne associated with leucocyte adhesion deficiency due to novel mutations in ITGB2: successful treatment with infliximab and adalimumab.
Vahlquist, Anders
Recurrent pyoderma gangrenosum and cystic acne associated with leucocyte adhesion deficiency due to novel mutations in ITGB2: successful treatment with infliximab and adalimumab. [electronic resource] - Acta dermato-venereologica Mar 2015 - 349-51 p. digital
Publication Type: Case Reports; Journal Article
1651-2057
10.2340/00015555-1929 doi
Acne Vulgaris--diagnosis
Adalimumab--therapeutic use
Adult
CD18 Antigens--genetics
Cysts--diagnosis
Drug Therapy, Combination
Genetic Predisposition to Disease
Humans
Immunosuppressive Agents--therapeutic use
Infliximab--therapeutic use
Leukocyte-Adhesion Deficiency Syndrome--diagnosis
Male
Mutation
Phenotype
Pyoderma Gangrenosum--diagnosis
Recurrence
Remission Induction
Treatment Outcome
Recurrent pyoderma gangrenosum and cystic acne associated with leucocyte adhesion deficiency due to novel mutations in ITGB2: successful treatment with infliximab and adalimumab. [electronic resource] - Acta dermato-venereologica Mar 2015 - 349-51 p. digital
Publication Type: Case Reports; Journal Article
1651-2057
10.2340/00015555-1929 doi
Acne Vulgaris--diagnosis
Adalimumab--therapeutic use
Adult
CD18 Antigens--genetics
Cysts--diagnosis
Drug Therapy, Combination
Genetic Predisposition to Disease
Humans
Immunosuppressive Agents--therapeutic use
Infliximab--therapeutic use
Leukocyte-Adhesion Deficiency Syndrome--diagnosis
Male
Mutation
Phenotype
Pyoderma Gangrenosum--diagnosis
Recurrence
Remission Induction
Treatment Outcome